Wednesday, July 22, 2026

Unlocking Weight Loss: How Celltrion’s New CT-G32 and Oral Multi-Action Drug Will Change the Game

Celltrion aims to lead the obesity treatment market with innovative drugs, enhancing efficacy and patient convenience through dual approaches.

North Korea Could Produce 400+ Nuclear Warheads by 2040, Defense Analyst Says

North Korea's nuclear production capacity is expanding, necessitating strategic negotiations to limit its growth and advance denuclearization.

JNPMedi Secures ISO 13485 Certification, Strengthening Its Medical Device Consulting Credibility

JNPMedi has achieved ISO 13485 certification, enhancing its quality management for clinical research and regulatory consulting in medical devices.

Tag: private enterprises

No posts to display

Top News

- Our Sponsors Ad -

Follow us